glp 1 autoimmune GLP-1 Receptor Agonists and Diseases Emerging Data Show Potential Risk

Liraglutide has a longer overall safety track record, having been approved for weight management since 2015, compared with semaglutide (Wegovy), which was approved for weight management in 2022

Kade is also a certified sports podiatrist and has published extensively, contributing to over 90 peerreviewed papers and presenting internationally

Leona E, Ling SR, Daly T, Cochran E, Tyler S, Markowitz L, et al

Table 1) [9, 10]

Metformin as a Maintenance Option Metformin, a well-established medication for type 2 diabetes, can be considered as a maintenance option post-GLP-1

Drug repositioning Drug repositioning is an alternative approach to identify new fields of application for existing drugs, currently approved for a different clinical condition